Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells

Immune checkpoint blockade (ICB) therapies can unleash anti-tumour T-cell responses. Here the authors show, by integrating MHC tetramer multiplexing, mass cytometry and high-dimensional analyses, that neoantigen-specific, tumour-infiltrating T cells are highly heterogeneous and are subjected to ICB...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: M. Fehlings, Y. Simoni, H. L. Penny, E. Becht, C. Y. Loh, M. M. Gubin, J. P. Ward, S. C. Wong, R. D. Schreiber, E. W. Newell
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/7858136795e54c05b2eaf80fa3fc40f9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7858136795e54c05b2eaf80fa3fc40f9
record_format dspace
spelling oai:doaj.org-article:7858136795e54c05b2eaf80fa3fc40f92021-12-02T14:42:39ZCheckpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells10.1038/s41467-017-00627-z2041-1723https://doaj.org/article/7858136795e54c05b2eaf80fa3fc40f92017-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-00627-zhttps://doaj.org/toc/2041-1723Immune checkpoint blockade (ICB) therapies can unleash anti-tumour T-cell responses. Here the authors show, by integrating MHC tetramer multiplexing, mass cytometry and high-dimensional analyses, that neoantigen-specific, tumour-infiltrating T cells are highly heterogeneous and are subjected to ICB modulations.M. FehlingsY. SimoniH. L. PennyE. BechtC. Y. LohM. M. GubinJ. P. WardS. C. WongR. D. SchreiberE. W. NewellNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
M. Fehlings
Y. Simoni
H. L. Penny
E. Becht
C. Y. Loh
M. M. Gubin
J. P. Ward
S. C. Wong
R. D. Schreiber
E. W. Newell
Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
description Immune checkpoint blockade (ICB) therapies can unleash anti-tumour T-cell responses. Here the authors show, by integrating MHC tetramer multiplexing, mass cytometry and high-dimensional analyses, that neoantigen-specific, tumour-infiltrating T cells are highly heterogeneous and are subjected to ICB modulations.
format article
author M. Fehlings
Y. Simoni
H. L. Penny
E. Becht
C. Y. Loh
M. M. Gubin
J. P. Ward
S. C. Wong
R. D. Schreiber
E. W. Newell
author_facet M. Fehlings
Y. Simoni
H. L. Penny
E. Becht
C. Y. Loh
M. M. Gubin
J. P. Ward
S. C. Wong
R. D. Schreiber
E. W. Newell
author_sort M. Fehlings
title Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
title_short Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
title_full Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
title_fullStr Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
title_full_unstemmed Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
title_sort checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific cd8+ t cells
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/7858136795e54c05b2eaf80fa3fc40f9
work_keys_str_mv AT mfehlings checkpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT ysimoni checkpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT hlpenny checkpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT ebecht checkpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT cyloh checkpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT mmgubin checkpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT jpward checkpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT scwong checkpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT rdschreiber checkpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
AT ewnewell checkpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
_version_ 1718389636465688576